Caribou Biosciences, Inc. (CRBU)
0.4487
+0.04
(+8.83%)
USD |
NASDAQ |
Nov 06, 16:00
0.4423
-0.01
(-1.43%)
After-Hours: 20:00
Caribou Biosciences Total Assets (Quarterly) : 123.03M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 123.03M |
| June 30, 2026 | 142.77M |
| March 31, 2026 | 149.00M |
| December 31, 2025 | 179.63M |
| September 30, 2025 | 194.98M |
| June 30, 2025 | 220.90M |
| March 31, 2025 | 273.66M |
| December 31, 2024 | 320.85M |
| September 30, 2024 | 344.33M |
| June 30, 2024 | 372.94M |
| March 31, 2024 | 406.82M |
| December 31, 2023 | 440.97M |
| Date | Value |
|---|---|
| September 30, 2023 | 457.52M |
| June 30, 2023 | 349.65M |
| March 31, 2023 | 347.46M |
| December 31, 2022 | 384.27M |
| September 30, 2022 | 398.82M |
| June 30, 2022 | 421.37M |
| March 31, 2022 | 446.00M |
| December 31, 2021 | 445.20M |
| September 30, 2021 | 461.96M |
| June 30, 2021 | 158.40M |
| March 31, 2021 | 170.45M |
| December 31, 2020 | 38.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | 120.14M |
| Vaxcyte, Inc. | 2.989B |
| Foghorn Therapeutics, Inc. | 203.39M |
| Bolt Biotherapeutics, Inc. | 40.34M |
| Connect Biopharma Holdings Ltd. | 43.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.39M |
| Shareholders Equity (Quarterly) | 76.63M |
| Debt to Equity Ratio | 0.3437 |
| Current Ratio | 4.968 |
| Net Debt Paydown Yield | -0.07% |